Case Report: Transarterial Chemoembolization in Combination With Tislelizumab Downstages Unresectable Hepatocellular Carcinoma Followed by Radical Salvage Resection
IntroductionTransarterial chemoembolization (TACE) is inefficient at converting unresectable hepatocellular carcinoma (uHCC) to resectable.Treatment with immune checkpoint inhibitors (ICIs) is an emerging strategy for uHCC.Combined therapy of TACE with ICIs is considered to Headband improve the therapeutic effect.Case presentationA 45-year-old man